MedPath
FDA Approval

Olanzapine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
NorthStar RxLLC
DUNS: 830546433
Effective Date
August 17, 2023
Labeling Type
Human Prescription Drug Label
Olanzapine(20 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Macleods Pharmaceuticals Limited

NorthStar RxLLC

676369519

Products6

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olanzapine

Product Details

NDC Product Code
72603-159
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
Code: N7U69T4SZRClass: ACTIBQuantity: 20 mg in 1 1
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT

Olanzapine

Product Details

NDC Product Code
72603-157
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
Code: N7U69T4SZRClass: ACTIBQuantity: 10 mg in 1 1
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT

Olanzapine

Product Details

NDC Product Code
72603-155
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
Code: N7U69T4SZRClass: ACTIBQuantity: 5 mg in 1 1
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT

Olanzapine

Product Details

NDC Product Code
72603-156
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
Code: N7U69T4SZRClass: ACTIBQuantity: 7.5 mg in 1 1
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT

Olanzapine

Product Details

NDC Product Code
72603-154
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
Code: N7U69T4SZRClass: ACTIBQuantity: 2.5 mg in 1 1
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT

Olanzapine

Product Details

NDC Product Code
72603-158
Application Number
ANDA202862
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 17, 2023
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
Code: N7U69T4SZRClass: ACTIBQuantity: 15 mg in 1 1
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
© Copyright 2025. All Rights Reserved by MedPath